(MDBA) UBS(Lux)Fund Solutions – - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU1852211215

Sustainable, Bank, Bonds, Government, ETF

Description: MDBA UBS(Lux)Fund Solutions –

The UBS(Lux)Fund Solutions – Sustainable Development Bank Bonds UCITS ETF(USD)A-acc is an exchange-traded fund listed on the XETRA exchange with the ticker symbol MDBA. It is designed to track the Morningstar US Govt Bd TR USD index, providing investors with exposure to US government bonds.

As a USD Government Bond ETF, MDBA invests in a portfolio of US government securities, offering a relatively low-risk investment option. The funds focus on sustainable development bank bonds aligns with the growing demand for environmentally and socially responsible investments.

Analyzing the funds technical data, we observe that the current price is 10.49, slightly below its 20-day and 50-day simple moving averages (SMA20 and SMA50) of 10.53 and 10.60, respectively. The 200-day simple moving average (SMA200) is 10.94, indicating a longer-term downtrend. The average true range (ATR) is 0.06, representing a 0.55% daily price volatility. The 52-week high and low prices are 11.44 and 10.41, respectively, suggesting a relatively stable price range.

From a fundamental perspective, the funds assets under management (AUM) stand at 699.86M EUR, indicating a moderate level of investor interest. As a UCITS-compliant ETF, MDBA is subject to strict regulatory requirements, providing an additional layer of investor protection.

Based on the available technical and fundamental data, we can forecast that MDBA may continue to experience a relatively stable price movement in the short term, potentially oscillating around its current price level. However, the longer-term downtrend indicated by the SMA200 may persist if the underlying market conditions remain unchanged. To mitigate potential risks, investors may consider monitoring the funds price movements and adjusting their investment strategies accordingly. A potential trading strategy could involve buying MDBA on dips towards its 52-week low (10.41) and selling on rallies towards its SMA20 (10.53) or SMA50 (10.60), with a stop-loss below 10.41 to limit potential losses.

Additional Sources for MDBA ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

MDBA ETF Overview

Market Cap in USD 824m
Category USD Government Bond
TER 0.20%
IPO / Inception 2018-11-08

MDBA ETF Ratings

Growth Rating 13.9
Fundamental -
Dividend Rating 0.0
Rel. Strength 0.66
Analysts -
Fair Price Momentum 8.98 EUR
Fair Price DCF -

MDBA Dividends

Currently no dividends paid

MDBA Growth Ratios

Growth Correlation 3m -73.7%
Growth Correlation 12m -14.9%
Growth Correlation 5y 67.5%
CAGR 5y -0.47%
CAGR/Max DD 5y -0.04
Sharpe Ratio 12m -0.62
Alpha -6.31
Beta -0.082
Volatility 6.31%
Current Volume 3.8k
Average Volume 20d 2.7k
Stop Loss 10 (-3.3%)
What is the price of MDBA shares?
As of July 09, 2025, the stock is trading at EUR 10.34 with a total of 3,812 shares traded.
Over the past week, the price has changed by +0.20%, over one month by -1.78%, over three months by -6.12% and over the past year by -2.65%.
Is UBS(Lux)Fund Solutions – a good stock to buy?
Neither. Based on ValueRay´s Analyses, UBS(Lux)Fund Solutions – is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 13.88 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MDBA is around 8.98 EUR . This means that MDBA is currently overvalued and has a potential downside of -13.15%.
Is MDBA a buy, sell or hold?
UBS(Lux)Fund Solutions – has no consensus analysts rating.
What are the forecasts for MDBA share price target?
According to our own proprietary Forecast Model, MDBA UBS(Lux)Fund Solutions – will be worth about 9.7 in July 2026. The stock is currently trading at 10.34. This means that the stock has a potential downside of -6.19%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 9.7 -6.2%